KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Equity Ratio: 2017-2025

Historic Equity Ratio for Aquestive Therapeutics (AQST) over the last 8 years, with Sep 2025 value amounting to -0.03.

  • Aquestive Therapeutics' Equity Ratio rose 93.92% to -0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.03, marking a year-over-year increase of 93.92%. This contributed to the annual value of -0.59 for FY2024, which is 68.02% up from last year.
  • Latest data reveals that Aquestive Therapeutics reported Equity Ratio of -0.03 as of Q3 2025, which was up 96.76% from -0.77 recorded in Q2 2025.
  • Aquestive Therapeutics' 5-year Equity Ratio high stood at -0.03 for Q3 2025, and its period low was -2.08 during Q3 2022.
  • For the 3-year period, Aquestive Therapeutics' Equity Ratio averaged around -0.93, with its median value being -0.60 (2025).
  • In the last 5 years, Aquestive Therapeutics' Equity Ratio slumped by 158.98% in 2021 and then spiked by 93.92% in 2025.
  • Aquestive Therapeutics' Equity Ratio (Quarterly) stood at -1.32 in 2021, then tumbled by 56.79% to -2.08 in 2022, then grew by 10.72% to -1.85 in 2023, then skyrocketed by 68.02% to -0.59 in 2024, then skyrocketed by 93.92% to -0.03 in 2025.
  • Its last three reported values are -0.03 in Q3 2025, -0.77 for Q2 2025, and -0.60 during Q1 2025.